Comparison of NN1250 With Insulin Glargine in Type 1 Diabetes
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe and in the United States of America (USA). The aim of this
trial is to investigate the efficacy and safety of NN1250 (insulin degludec) in subjects with
type 1 diabetes.